Publication
The invention relates to chemically disruptable molecule (CDM) switch, their use in controlling cell signaling components, and their use for treatments and therapies. Further disclosed are methods of treating and/or preventing a disease, such as e.g. a cancer, an inflammatory disease, a genetic disorder, an infectious disease, and a degenerative disease